本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

47.77
+0.60001.27%
盘后47.16-0.6100-1.28%17:09 EST
成交量:46.86万
成交额:2,223.65万
市值:36.21亿
市盈率:102.33
高:47.86
开:47.46
低:46.75
收:47.17
52周最高:47.86
52周最低:18.26
股本:7,579.58万
流通股本:3,524.44万
量比:1.04
换手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):0.4668
每股收益(LYR):-0.6047
净资产收益率:7.39%
总资产收益率:3.76%
市净率:6.76
市盈率(LYR):-78.99

数据加载中...

2026/01/14

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities